Parkinson’s Disease Drug Permax Ordered Off The Market By Health Canada
September 5th, 2007 Posted by: Dr. Cox
Permax Was Voluntarily Withdrawn From the U.S. Market Earlier This Year At The Insistence of FDA
(Posted by Tom Lamb at DrugInjuryWatch.com)
As you may recall, the Parkinson disease drug Permax was voluntarily withdrawn from the U.S. market in late March 2007 after studies in the New England Journal of Medicine underscored the increased risk of serious heart valve damage associated with Permax.
In Canada, however, Eli Lilly Canada Inc. had continued to sell Permax (pergolide).